Jade Biosciences, Inc.
Jade Biosciences, Inc. (JBIO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · JBIO · as of Jun 9, 2026
Key Statistics
Explore Jade Biosciences, Inc. Data
jbio stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
The JBIO analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $44.20, representing +195.06% upside from the current price of $14.98.
Competitors & Peers
jbio competitorsJBIO
ACIU
ALDX
CTNM
GNLX
KYTXStock Performance
Full HistoryAbout Jade Biosciences, Inc.
Jade Biosciences, Inc. operates as a biotechnology enterprise, primarily focused on pioneering superior therapeutic solutions for significant unmet medical requirements in autoimmune disorders. Its le…
what is jade biosciences, inc. · jbio stock overview · jade biosciences, inc. company profile · who is jade biosciences, inc. ceo · jbio NASDAQ · jade biosciences, inc. headquarters · jade biosciences, inc. business segments
About Stock Overview & Key Data
Jade Biosciences, Inc. (JBIO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 29, 2025. As of the latest trading session, JBIO stock price is $14.98, with a market capitalization of $488.7M. The stock has returned +94.29% over the past 12 months and -2.92% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Jade Biosciences, Inc. stock is Buy, with an average 12-month price target of $44.20. In fiscal year 2025, Jade Biosciences, Inc. reported revenue of — and net income of -$127.4M. For detailed data — including Jade Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Jade Biosciences, Inc. (JBIO) stock price is $14.98. The stock is traded on NASDAQ under the ticker symbol JBIO. The 52-week range is $6.57 – $28.00.